This is a snippet of the transcript, sign up to read more.
The support from Safran and GE, specifically CFM, was crucial for establishing more blade repair capability on the CFM56 platform in Asia Pacific. The belief was that replicating what was already done in El Cajon would make airworthiness authorities more agreeable, which they were. It potentially streamlined the approval process. It was replication, but also investment. We assumed we could win LEAP blade repair and gear turbofan work, among other products. We invested in equipment for future volumes and repair capabilities that we weren't handling at that time. It was a significant investment in automation and technical capability, including machinery and inspection capability. It was a substantial upgrade of what they were doing in El Cajon.
This is a snippet of the transcript, sign up to read more.
The thing is, it's not unilateral across the repair business. Fan blades are the first things off and the last things on the engine. If your turn time is longer than the marshalling time, which is the engine marshalling time, it can affect the process. Stop me if I'm teaching you to suck eggs. The marshalling time of the engine is essentially the time off wing, from when they start the teardown to when it can be on the test rig for power tests. We used to say 60 days, for example. It's probably different now and varies per engine and shop.
This is a snippet of the transcript, sign up to read more.
This document may not be reproduced, distributed, or transmitted in any form or by any means including resale of any part, unauthorised distribution to a third party or other electronic methods, without the prior written permission of IP 1 Ltd.
IP 1 Ltd, trading as In Practise (herein referred to as "IP") is a company registered in England and Wales and is not a registered investment advisor or broker-dealer, and is not licensed nor qualified to provide investment advice.
In Practise reserves all copyright, intellectual and other property rights in the Content. The information published in this transcript (“Content”) is for information purposes only and should not be used as the sole basis for making any investment decision. Information provided by IP is to be used as an educational tool and nothing in this Content shall be construed as an offer, recommendation or solicitation regarding any financial product, service or management of investments or securities. The views of the executive expressed in the Content are those of the expert and they are not endorsed by, nor do they represent the opinion of In Practise. In Practise makes no representations and accepts no liability for the Content or for any errors, omissions, or inaccuracies will in no way be held liable for any potential or actual violations of laws, including without limitation any securities laws, based on Information sent to you by In Practise.
© 2024 IP 1 Ltd. All rights reserved.
Subscribe to access hundreds of interviews and primary research